BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11502962)

  • 1. Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts.
    Hausen B; Boeke K; Berry GJ; Morris RE
    Transplantation; 2001 Aug; 72(3):364-8. PubMed ID: 11502962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of indefinite cardiac allograft survival correlates with toll-like receptor 2 and 4 downregulation after serine protease inhibitor-1 (Serp-1) treatment.
    Jiang J; Arp J; Kubelik D; Zassoko R; Liu W; Wise Y; Macaulay C; Garcia B; McFadden G; Lucas AR; Wang H
    Transplantation; 2007 Nov; 84(9):1158-67. PubMed ID: 17998872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
    Simonson MS; Robinson AV; Schulak JA; Hricik DE
    Transplantation; 2002 Apr; 73(7):1054-9. PubMed ID: 11965031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of chronic renal allograft rejection by SERP-1 protein.
    Bédard EL; Jiang J; Arp J; Qian H; Wang H; Guan H; Liu L; Parry N; Kim P; Garcia B; Li X; Macaulay C; McFadden G; Lucas A; Zhong R
    Transplantation; 2006 Mar; 81(6):908-14. PubMed ID: 16570016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
    Hausen B; Klupp J; Christians U; Higgins JP; Baumgartner RE; Hook LE; Friedrich S; Celnicker A; Morris RE
    Transplantation; 2001 Sep; 72(6):1128-37. PubMed ID: 11579312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
    Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
    Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
    Poston RS; Billingham M; Hoyt EG; Pollard J; Shorthouse R; Morris RE; Robbins RC
    Circulation; 1999 Jul; 100(1):67-74. PubMed ID: 10393683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
    Czer LS; Wong AV; Soukiasian H; Gallagher S; De Robertis M; Trento A
    Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine.
    Madsen JC; Yamada K; Allan JS; Choo JK; Erhorn AE; Pins MR; Vesga L; Slisz JK; Sachs DH
    Transplantation; 1998 Feb; 65(3):304-13. PubMed ID: 9484744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of tolerance induction and prevention of cardiac allograft vasculopathy in miniature swine: the effect of augmentation of donor antigen load.
    Yamada K; Mawulawde K; Menard MT; Shimizu A; Aretz HT; Choo JK; Allison KS; Slisz JK; Sachs DH; Madsen JC
    J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):709-19. PubMed ID: 10733759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin in combination with rad significantly reduces graft vascular disease in rat cardiac allografts.
    Gregory CR; Katznelson S; Griffey SM; Kyles AE; Berryman ER
    Transplantation; 2001 Sep; 72(6):989-93. PubMed ID: 11579289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model.
    Claerhout I; Beele H; Verstraete A; Van den Broecke C; Kestelyn P
    Graefes Arch Clin Exp Ophthalmol; 2001 Feb; 239(2):152-7. PubMed ID: 11372546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional immunomodulation enhances cardiac allograft survival in rats treated with donor-specific transfusion and cyclosporine.
    Levy AE; Alexander JW
    Transplantation; 1995 Oct; 60(8):812-5. PubMed ID: 7482740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators.
    Tanaka M; Gunawan F; Terry RD; Inagaki K; Caffarelli AD; Hoyt G; Tsao PS; Mochly-Rosen D; Robbins RC
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
    Stepkowski SM; Wang ME; Condon TP; Cheng-Flournoy S; Stecker K; Graham M; Qu X; Tian L; Chen W; Kahan BD; Bennett CF
    Transplantation; 1998 Sep; 66(6):699-707. PubMed ID: 9771832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection.
    Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC
    Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.